Melanocytic nevus pathophysiology
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Melanocytic nevus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Melanocytic nevus pathophysiology On the Web |
American Roentgen Ray Society Images of Melanocytic nevus pathophysiology |
Risk calculators and risk factors for Melanocytic nevus pathophysiology |
Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1];Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2] Michel C. Samson, M.D., FRCSC, FACS [3]
Overview
Melanocytic nevus is a benign growth on the skin (usually tan, brown, or flesh-colored) that contains a cluster of melanocytes and surrounding supportive tissue.
Pathophysiology
Congenital melanocytic nevi (CMN)
- When melanocytic nevi are present at birth or within the first few months of life they are known as Congenital melanocytic nevi (CMN).
- Congenital melanocytic nevi (CMN) are hamartomas lesions.
- Small melanocytic nevi that appear during early childhood between three months and two years of age, resemble true CMN clinicaly and histologicaly and are known as "tardive CMN," "early-onset nevi," and "congenital nevus-like nevi.[1]
- During embryogenesis clonal proliferations of benign melanocytes may give rise to melanocytic nevi.[2][3]
- BRAF V600E mutations have a very high corelation with small congenital melanocytic nevi (CMN), acquired melanocytic nevi and cutaneous melanomas.[4][5]
- While giant congenital melanocytic nevi (CMN) have somatic gain-of-function mutations in NRAS.[6][7]
- Compared to acquired melanocytic nevi, CMN penetrate into deeper layers of dermis.[8]
- Melanocytes in CMN follow pathyway of nerves and vessels and grow along adenxal structures (eg, hair follicles, sebaceous glands, eccrine ducts) and settle between collagen bundles in a single arrangement.[9][10]
Dermoscopic features of Congenital melanocytic nevi (CMN)
- CMN and acquired melanocytic nevi appear as pigment network, aggregated globules, or diffuse homogeneous brown pigmentation on dermoscopy.[11]
- Dermoscopic patterns that are commonly seen in CMN are:[12]
- Reticular
- Globular/cobblestoning
- Homogenous
- Or a mixture of these (ie, multicomponent)
- CMN may exhibit exaggerated attributes on dermoscopy compared to acquired melanocytic nevi, they may show:[13][14][14]
- Perifollicular hypopigmentation
- Marked follicular structures
- Skin hyperpigmentation
- Hypertrichosis
- Pigment changes surrounding follicles such as hypopigmentation
Gross Pathology
![](/images/a/a0/Mole_%28body_part%29.jpg)
Proliferative nodules Melanocytic nevus
- Benign melanocytic proliferations may occasionally appear within large or giant CMN.[15]
- They may be congenital or develop in infancy or childhood.
- They may grow rapidly with clinical characteristics of firmness or ulceration, in that case, a biopsy should be performed to eliminate melanoma.
- Large, atypical melanocytes and mitoses may be present on microscopy that make it difficult to differentiate from Melanoma.
- In case of difficulty in differentiating benign melanocytic proliferation from Melanoma on microscopy, an evaluation of an experienced doctor may be helpful. Other modalities of evaluation are comparative genomic hybridization or mass spectroscopy imaging proteomic analysis.[15][16]
Speckled lentiginous nevus (SLN)
- Speckled lentiginous nevus (SLN) or nevus spilus is a hyperpigmented, macular, patch-type, tan or light brown patch with superimposed darker brown macules and papules (picture 14A-B). The "background" tan patch (café-au-lait macule-like) of an SLN is usually noted at birth or soon after, with brown "spots" appearing within the lesion over time.
The superimposed, pigmented macules and papules can range from lentigines to junctional, compound, and intradermal nevi to Spitz nevi and blue nevi. There are two distinct subtypes of SLN: those with only macular speckles and those with papular as well as macular speckles [55].
Several lines of evidence suggest that SLN, which have a prevalence of approximately 2 percent, represent a subtype of CMN [56]. Some SLN have patterns of distribution reflecting embryonic development (eg, block-like with a sharp demarcation at the midline or following the lines of Blaschko).
The risk of developing melanoma in SLN is thought to be similar to classic CMN of the same size range. SLN should therefore be followed clinically with periodic examinations and biopsy of suspicious areas. (See 'Management' above and "Risk factors for the development of melanoma", section on 'Congenital nevi'.)
Complications of Melanocytic nevi
Melanoma
- Melanoma may arise as a complication within congenital melanocytic nevi(CMN), the lifetime risk is lower than 1%.[2]
- Melanoma arises at the dermal-epidermal junction, in giant CMN they may arise in the deeper layers.
- In large or giant CMN, there is 2 to 5 percent lifetime risk of developing either cutaneous or extracutaneous melanoma.[17]
- Half of the Melanoma may arise within the first five years of life.[18][19]
- Early identification and assessment may be difficult in giant CMN, becuase of there subepidermal location in cutaneous melanomas.
- Palpation of the lesion during physical exam may help in detecting deeper nodules.
- Primary melanoma may arise in the central nervous system (CNS) or retroperitoneum.
- Posterior axial giant CMN have the greateset risk of developing Melanomas, nevi of head and extrimities are less likely to develop melanomas.
Neurocutaneous melanosis
- Rarely in CMN neurocutaneous melanosis(NCM) may arise, it is the growth of melanocytes in CNS and skin.
- Neurocutaneous melanosis (NCM) includes leptomeningeal melanosis and CNS melanosis.[20]
- NCM is diagnosed on MRI as it may stay asymptomatic or produce minimal symptoms.[18]
- Symptomatic NCM has a poor prognosis with high mortality rate.[17]
- Risk factors for NCM are:[21][22][23]
- A large CMN, >40 cm and in a posterior axial location
- Multiple satellite nevi
- Greater than two medium-sized CMN
- According to a study CMN with >20 satellites had a fivefold increased risk for NCM compared with those with ≤20 satellites.[24]
- NCM may cooccur with the structural abnormalities of CNS such as Dandy-Walker malformation/posterior fossa cysts, defects of the vertebrae or skull, and intraspinal lipomas.[24]
- MRI with gadolinium contrast can pick NCM.[22]
- Symptomatic NCM may present with hydrocephalus, seizures that may be consequence of intracranial hemorrhage, impaired cerebrospinal fluid circulation, spinal cord compression, or malignant transformation of the melanocytes.[25]
- If symptomatic NCM have poor prognosis even with abscence of malignant changes.[26]
References
- ↑ Makkar HS, Frieden IJ (August 2002). "Congenital melanocytic nevi: an update for the pediatrician". Curr. Opin. Pediatr. 14 (4): 397–403. PMID 12130901.
- ↑ 2.0 2.1 Tannous ZS, Mihm MC, Sober AJ, Duncan LM (February 2005). "Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management". J. Am. Acad. Dermatol. 52 (2): 197–203. doi:10.1016/j.jaad.2004.07.020. PMID 15692463.
- ↑ Price HN, Schaffer JV (2010). "Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies". Clin. Dermatol. 28 (3): 293–302. doi:10.1016/j.clindermatol.2010.04.004. PMID 20541682.
- ↑ Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T (September 2006). "High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi". J. Invest. Dermatol. 126 (9): 2111–8. doi:10.1038/sj.jid.5700366. PMID 16691193.
- ↑ Wu J, Rosenbaum E, Begum S, Westra WH (December 2007). "Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis". Am J Dermatopathol. 29 (6): 534–7. doi:10.1097/DAD.0b013e3181584950. PMID 18032947.
- ↑ Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, Van den Eynde BJ, Ma W, Roseeuw D, Vassart G, Libert F, Heimann P (January 2009). "Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis". J. Invest. Dermatol. 129 (1): 139–47. doi:10.1038/jid.2008.203. PMID 18633438.
- ↑ Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, How-Kit A, Su X, Coulomb-L'Hermine A, Tost J, Mourah S, Aractingi S, Guégan S (April 2014). "NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi". J. Invest. Dermatol. 134 (4): 1067–1074. doi:10.1038/jid.2013.429. PMID 24129063.
- ↑ Mark GJ, Mihm MC, Liteplo MG, Reed RJ, Clark WH (September 1973). "Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies". Hum. Pathol. 4 (3): 395–418. PMID 4756859.
- ↑ "Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, Oct. 24-26, 1983". J. Am. Acad. Dermatol. 10 (4): 683–8. April 1984. PMID 6715623.
- ↑ Kokta V, Hung T, Al Dhaybi R, Lugassy C, Barnhill RL (April 2013). "High prevalence of angiotropism in congenital melanocytic nevi: an analysis of 53 cases". Am J Dermatopathol. 35 (2): 180–3. doi:10.1097/DAD.0b013e318260908c. PMID 22771898.
- ↑ Haliasos EC, Kerner M, Jaimes N, Zalaudek I, Malvehy J, Hofmann-Wellenhof R, Braun RP, Marghoob AA (2013). "Dermoscopy for the pediatric dermatologist part III: dermoscopy of melanocytic lesions". Pediatr Dermatol. 30 (3): 281–93. doi:10.1111/pde.12041. PMID 23252411.
- ↑ Changchien L, Dusza SW, Agero AL, Korzenko AJ, Braun RP, Sachs D, Usman MH, Halpern AC, Marghoob AA (August 2007). "Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic nevi". Arch Dermatol. 143 (8): 1007–14. doi:10.1001/archderm.143.8.1007. PMID 17709659.
- ↑ Seidenari S, Pellacani G, Martella A, Giusti F, Argenziano G, Buccini P, Carli P, Catricalà C, De Giorgi V, Ferrari A, Ingordo V, Manganoni AM, Peris K, Piccolo D, Pizzichetta MA (July 2006). "Instrument-, age- and site-dependent variations of dermoscopic patterns of congenital melanocytic naevi: a multicentre study". Br. J. Dermatol. 155 (1): 56–61. doi:10.1111/j.1365-2133.2006.07182.x. PMID 16792752.
- ↑ 14.0 14.1 Ingordo V, Iannazzone SS, Cusano F, Naldi L (2006). "Dermoscopic features of congenital melanocytic nevus and Becker nevus in an adult male population: an analysis with a 10-fold magnification". Dermatology (Basel). 212 (4): 354–60. doi:10.1159/000092286. PMID 16707885.
- ↑ 15.0 15.1 Phadke PA, Rakheja D, Le LP, Selim MA, Kapur P, Davis A, Mihm MC, Hoang MP (May 2011). "Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases". Am. J. Surg. Pathol. 35 (5): 656–69. doi:10.1097/PAS.0b013e31821375ea. PMID 21436676.
- ↑ Lazova R, Yang Z, El Habr C, Lim Y, Choate KA, Seeley EH, Caprioli RM, Yangqun L (September 2017). "Mass Spectrometry Imaging Can Distinguish on a Proteomic Level Between Proliferative Nodules Within a Benign Congenital Nevus and Malignant Melanoma". Am J Dermatopathol. 39 (9): 689–695. doi:10.1097/DAD.0000000000000849. PMC 5647999. PMID 28248717.
- ↑ 17.0 17.1 Vourc'h-Jourdain M, Martin L, Barbarot S (March 2013). "Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review". J. Am. Acad. Dermatol. 68 (3): 493–8.e1–14. doi:10.1016/j.jaad.2012.09.039. PMID 23182059.
- ↑ 18.0 18.1 Watt AJ, Kotsis SV, Chung KC (June 2004). "Risk of melanoma arising in large congenital melanocytic nevi: a systematic review". Plast. Reconstr. Surg. 113 (7): 1968–74. PMID 15253185.
- ↑ Kinsler VA, Birley J, Atherton DJ (January 2009). "Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes". Br. J. Dermatol. 160 (1): 143–50. doi:10.1111/j.1365-2133.2008.08849.x. PMID 18811688.
- ↑ Foster RD, Williams ML, Barkovich AJ, Hoffman WY, Mathes SJ, Frieden IJ (April 2001). "Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children". Plast. Reconstr. Surg. 107 (4): 933–41. PMID 11252085.
- ↑ DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Wasti Q, Huang CL, Kopf AW, Bart RS (October 1996). "Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis". J. Am. Acad. Dermatol. 35 (4): 529–38. PMID 8859278.
- ↑ 22.0 22.1 Kinsler VA, Chong WK, Aylett SE, Atherton DJ (September 2008). "Complications of congenital melanocytic naevi in children: analysis of 16 years' experience and clinical practice". Br. J. Dermatol. 159 (4): 907–14. doi:10.1111/j.1365-2133.2008.08775.x. PMID 18671780.
- ↑ Lovett A, Maari C, Decarie JC, Marcoux D, McCuaig C, Hatami A, Savard P, Powell J (November 2009). "Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center's experience". J. Am. Acad. Dermatol. 61 (5): 766–74. doi:10.1016/j.jaad.2008.11.022. PMID 19766348.
- ↑ 24.0 24.1 Marghoob AA, Dusza S, Oliveria S, Halpern AC (February 2004). "Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi". Arch Dermatol. 140 (2): 171–5. doi:10.1001/archderm.140.2.171. PMID 14967788.
- ↑ Di Rocco F, Sabatino G, Koutzoglou M, Battaglia D, Caldarelli M, Tamburrini G (January 2004). "Neurocutaneous melanosis". Childs Nerv Syst. 20 (1): 23–8. doi:10.1007/s00381-003-0835-9. PMID 14576958.
- ↑ Schaffer JV, McNiff JM, Bolognia JL (2001). "Cerebral mass due to neurocutaneous melanosis: eight years later". Pediatr Dermatol. 18 (5): 369–77. PMID 11737677.